| 000 | 01104 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250511215749.0 | ||
| 264 | 0 | _c19910508 | |
| 008 | 199105s 0 0 eng d | ||
| 022 | _a0027-5107 | ||
| 024 | 7 |
_a10.1016/0027-5107(91)90022-g _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNebert, D W | |
| 245 | 0 | 0 |
_aRole of genetics and drug metabolism in human cancer risk. _h[electronic resource] |
| 260 |
_bMutation research _cApr 1991 |
||
| 300 |
_a267-81 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAcetylation |
| 650 | 0 | 4 |
_aAryl Hydrocarbon Hydroxylases _xmetabolism |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xgenetics |
| 650 | 0 | 4 | _aDebrisoquin |
| 650 | 0 | 4 | _aGene Expression Regulation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xchemically induced |
| 650 | 0 | 4 |
_aPharmaceutical Preparations _xmetabolism |
| 650 | 0 | 4 | _aPharmacogenetics |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 773 | 0 |
_tMutation research _gvol. 247 _gno. 2 _gp. 267-81 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0027-5107(91)90022-g _zAvailable from publisher's website |
| 999 |
_c2017323 _d2017323 |
||